US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.813
  • -0.018-2.11%
Close Jul 22 16:00 ET
64.95MMarket Cap-1083P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 28, 2024

Revenue(YoY)

6.86M

0.00%
EPS(YoY)

-<0.01

+93.59%
Analyst Rating

Buy

Feb 23, 2024

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.660M--
--2024/Q2-- / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--
Nov 20, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.660M--
--2024/Q2-- / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--
Nov 20, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    May 28 07:16 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 1 10:36 ET

  • BioLine Rx | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Mar 26 17:00 ET

  • BioLine Rx | 20-F: Registration statement / Annual report / Transition report

    Mar 26 08:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Feb 23, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg